Advances and breakthroughs in prostate disease
Reviewed by Per-Anders Abrahamsson, M.D., Ph.D.
Advances in the understanding and treatment of prostate disease are constantly being reported at scientific meetings and in peer-reviewed publications. What follows are some of the most interesting recent findings, placed in context by Dr. Abrahamsson, a member of Perspectives' editorial and advisory board and Secretary General of the European Association of Urology, the leading professional organization overseas.
Statins show no effect on PSA levels
Ever since the FDA approved the first cholesterol-lowering statin in 1987, use of the drugs has steadily increased, with an estimated 13 million Americans taking them to ward off heart and vascular disease. Recently, statins have gained additional attention, thanks to studies showing the drugs might have anticancer properties.